Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
Carolina Ayelen IsnardiDeshiré Alpizar-RodriguezDébora Cerqueira CalderaroClaudia Diniz Lopes MarquesGuillermo Javier Pons-EstelRicardo Machado XavierVerónica SauritCecilia Nora PisoniYohana Soledad TisseraMaria Eugenia D'Angelo ExeniPaula AlbaDora PereiraCarla Andrea GobbiMaría Julieta GambaMaría Agustina AlfaroBelén María VirasoroIris Jazmin Colunga-PedrazaFedra Irazoque-PalazuelosGreta Reyes-CorderoTatiana Sofía Rodríguez ReynaJose Antonio Veloz-ArandaCassandra Michelle Skinner-TaylorIngrid Maribel Juárez-MoraLuis H SilveiraCesar Francisco Pacheco TenaDaniel Xavier Xibille-FriedmannGilda Aparecida Aparecida FerreiraAdriana Maria KakehasiMarcelo De Medeiros PinheiroAna Paula Monteiro Gomides ReisGecilmara Cristina Salviato PileggiLicia Maria Henrique da MotaEdgard Torres Dos Reis-NetoSandra Lucia Euzébio RibeiroLilian David de Azevedo ValadaresMarco Ulises Martínez-MartínezPublished in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2023)
Mortality in patients with IMIDs was particularly high in Mexicans. Ethnic, environmental, societal factors, and different COVID-19 mitigation measures adopted have probably influenced these results.